Home12V • FRA
add
Veracyte Inc
Previous close
€28.64
Day range
€28.49 - €28.49
Year range
€19.50 - €42.60
Market cap
2.62B USD
Avg Volume
8.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 140.64M | 18.55% |
Operating expense | 70.67M | 10.72% |
Net income | 41.15M | 704.79% |
Net profit margin | 29.26 | 578.89% |
Earnings per share | 0.53 | 47.22% |
EBITDA | 29.91M | 112.03% |
Effective tax rate | -1.27% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 412.89M | 42.65% |
Total assets | 1.41B | 8.15% |
Total liabilities | 96.44M | -22.27% |
Total equity | 1.31B | — |
Shares outstanding | 79.46M | — |
Price to book | 1.74 | — |
Return on assets | 4.44% | — |
Return on capital | 4.65% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 41.15M | 704.79% |
Cash from operations | 52.58M | 114.41% |
Cash from investing | -5.43M | 89.97% |
Cash from financing | -149.00K | 96.70% |
Net change in cash | 47.02M | 236.17% |
Free cash flow | 23.13M | -6.42% |
About
Founded
2006
Headquarters
Website
Employees
755
